312 related articles for article (PubMed ID: 21632813)
1. Medical and surgical evaluation and treatment of adrenal incidentalomas.
Zeiger MA; Siegelman SS; Hamrahian AH
J Clin Endocrinol Metab; 2011 Jul; 96(7):2004-15. PubMed ID: 21632813
[TBL] [Abstract][Full Text] [Related]
2. [Incidentaloma and subclinical disorders of the adrenal gland].
Fischer E; Beuschlein F
Dtsch Med Wochenschr; 2013 Feb; 138(8):375-80. PubMed ID: 23404326
[TBL] [Abstract][Full Text] [Related]
3. NIH state-of-the-science statement on management of the clinically inapparent adrenal mass ("incidentaloma").
NIH Consens State Sci Statements; 2002 Feb 4-6; 19(2):1-25. PubMed ID: 14768652
[TBL] [Abstract][Full Text] [Related]
4. Is biochemical screening for pheochromocytoma in adrenal incidentalomas expressing low unenhanced attenuation on computed tomography necessary?
Sane T; Schalin-Jäntti C; Raade M
J Clin Endocrinol Metab; 2012 Jun; 97(6):2077-83. PubMed ID: 22492870
[TBL] [Abstract][Full Text] [Related]
5. [Adrenal incidentalomas: etiologic diagnostics and basic therapeutic management. A mini-review].
Alberti C
G Chir; 2009 May; 30(5):243-50. PubMed ID: 19505420
[TBL] [Abstract][Full Text] [Related]
6. Preclinical Cushing's syndrome in adrenal "incidentalomas": comparison with adrenal Cushing's syndrome.
Reincke M; Nieke J; Krestin GP; Saeger W; Allolio B; Winkelmann W
J Clin Endocrinol Metab; 1992 Sep; 75(3):826-32. PubMed ID: 1517373
[TBL] [Abstract][Full Text] [Related]
7. Subclinical Cushing's syndrome in patients with adrenal incidentaloma: clinical and biochemical features.
Rossi R; Tauchmanova L; Luciano A; Di Martino M; Battista C; Del Viscovo L; Nuzzo V; Lombardi G
J Clin Endocrinol Metab; 2000 Apr; 85(4):1440-8. PubMed ID: 10770179
[TBL] [Abstract][Full Text] [Related]
8. European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors.
Fassnacht M; Tsagarakis S; Terzolo M; Tabarin A; Sahdev A; Newell-Price J; Pelsma I; Marina L; Lorenz K; Bancos I; Arlt W; Dekkers OM
Eur J Endocrinol; 2023 Jul; 189(1):G1-G42. PubMed ID: 37318239
[TBL] [Abstract][Full Text] [Related]
9. Adrenal incidentaloma.
Arnaldi G; Masini AM; Giacchetti G; Taccaliti A; Faloia E; Mantero F
Braz J Med Biol Res; 2000 Oct; 33(10):1177-89. PubMed ID: 11004718
[TBL] [Abstract][Full Text] [Related]
10. [Clinical management of adrenal incidentalomas: results of a survey].
Moreno-Fernández J; García-Manzanares A; Sánchez-Covisa MA; García EI
Endocrinol Nutr; 2009 Dec; 56(10):447-51. PubMed ID: 20114014
[TBL] [Abstract][Full Text] [Related]
11. Approach to the patient with an adrenal incidentaloma.
Nieman LK
J Clin Endocrinol Metab; 2010 Sep; 95(9):4106-13. PubMed ID: 20823463
[TBL] [Abstract][Full Text] [Related]
12. Management of adrenal incidentalomas: European Society of Endocrinology Clinical Practice Guideline in collaboration with the European Network for the Study of Adrenal Tumors.
Fassnacht M; Arlt W; Bancos I; Dralle H; Newell-Price J; Sahdev A; Tabarin A; Terzolo M; Tsagarakis S; Dekkers OM
Eur J Endocrinol; 2016 Aug; 175(2):G1-G34. PubMed ID: 27390021
[TBL] [Abstract][Full Text] [Related]
13. Hormonal activity of adrenal incidentalomas: results from a long-term follow-up study.
Vassilatou E; Vryonidou A; Michalopoulou S; Manolis J; Caratzas J; Phenekos C; Tzavara I
Clin Endocrinol (Oxf); 2009 May; 70(5):674-9. PubMed ID: 19067718
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of quantitative parameters for distinguishing pheochromocytoma from other adrenal tumors.
Ohno Y; Sone M; Taura D; Yamasaki T; Kojima K; Honda-Kohmo K; Fukuda Y; Matsuo K; Fujii T; Yasoda A; Ogawa O; Inagaki N
Hypertens Res; 2018 Mar; 41(3):165-175. PubMed ID: 29348428
[TBL] [Abstract][Full Text] [Related]
15. Incidental and metastatic adrenal masses.
Mannelli M; Colagrande S; Valeri A; Parenti G
Semin Oncol; 2010 Dec; 37(6):649-61. PubMed ID: 21167383
[TBL] [Abstract][Full Text] [Related]
16. Two-year follow-up of thirty-two non-functional benign adrenal incidentalomas.
Yilmaz H; Tütüncü NB; Sahin M
J Endocrinol Invest; 2009 Dec; 32(11):913-6. PubMed ID: 19605976
[TBL] [Abstract][Full Text] [Related]
17. Optimal follow-up strategies for adrenal incidentalomas: reappraisal of the 2016 ESE-ENSAT guidelines in real clinical practice.
Hong AR; Kim JH; Park KS; Kim KY; Lee JH; Kong SH; Lee SY; Shin CS; Kim SW; Kim SY
Eur J Endocrinol; 2017 Dec; 177(6):475-483. PubMed ID: 28870984
[TBL] [Abstract][Full Text] [Related]
18. [Adrenal incidentalomas: clinical experience in the hospitals of Castilla-La Mancha (Spain)].
Lamas C; Palma M; Martín D; de Frutos VA; López M; Marco A
Endocrinol Nutr; 2009 Oct; 56(8):392-9. PubMed ID: 19959148
[TBL] [Abstract][Full Text] [Related]
19. A new risk stratification algorithm for the management of patients with adrenal incidentalomas.
Birsen O; Akyuz M; Dural C; Aksoy E; Aliyev S; Mitchell J; Siperstein A; Berber E
Surgery; 2014 Oct; 156(4):959-65. PubMed ID: 25239353
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic and therapeutic strategy for an incidental finding of an adrenal mass].
Alves A; Scatton O; Dousset B
J Chir (Paris); 2002 Sep; 139(4):205-13. PubMed ID: 12410136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
